Advertisement
News
Subscribe to MDT Magazine News

Nanostart-Holding Nanosys: Distribution Agreement with Multi-Billion Dollar Cooperation Sigma-Aldrich

December 3, 2010 7:36 pm | by I-Micronews | Comments

(BUSINESS WIRE)--Nanostart (OTCQX:NASRY)-holding Nanosys has entered into a distribution agreement with multi-billion dollar concern Sigma-Aldrich (Nasdaq: SIAL).

IDRI Awarded Contract from BARDA to Develop Next Generation Adjuvants for Pandemic Influenza

December 3, 2010 7:35 pm | by Bio-Medicine.Org | Comments

SEATTLE, Dec. 4, 2010 /PRNewswire-USNewswire/ -- The Infectious Disease Research Institute (IDRI) has been awarded an $1.8 million contract from the Biomedical Advance Research and Development Authority (BARDA). IDRI's work will focus on development of adjuvant formulations with options...

TOPICS:

Citing New Technologies, FDA Updates C. Difficile Guidance(3)

December 3, 2010 2:42 pm | by U.S. Food & Drug Administration | Comments

Recognizing new issues facing sponsors of diagnostics to detect Clostridium difficile infections, the FDA has updated its 20-year-old guidance on establishing the performance characteristics of new tests.

Advertisement

Anchor Products Gets a Warning for Complaint Handling, MDRs

December 3, 2010 2:34 pm | by U.S. Food & Drug Administration | Comments

Anchor Products has received a warning letter citing it for a number of issues, including handling of complaints and medical device reports (MDRs).

TOPICS:

Citing New Technologies, FDA Updates C. Difficile Guidance(2)

December 3, 2010 2:33 pm | Comments

Recognizing new issues facing sponsors of diagnostics to detect Clostridium difficile infections, the FDA has updated its 20-year-old guidance on establishing the performance characteristics of new tests.

Citing New Technologies, FDA Updates C. Difficile Guidance

December 3, 2010 2:32 pm | Comments

Recognizing new issues facing sponsors of diagnostics to detect Clostridium difficile infections, the FDA has updated its 20-year-old guidance on establishing the performance characteristics of new tests.

Klafter Olsen & Lesser, LLP Announces That a Securities Class Action Has Been Filed Against MELA Sciences, Inc.

December 3, 2010 1:45 pm | by The Associated Press | Comments

Klafter Olsen & Lesser LLP ("KOL") announces that a securities class action complaint against MELA Sciences, Inc. ("MELA Sciences" or the "Company") (NASDAQ: MELA) and certain of its officers has been filed in the U.S. District Court for the Southern District of New York on behalf of...

Aetna increases buyback plans by $750 million

December 3, 2010 11:46 am | by The Associated Press | Comments

Health insurer Aetna Inc. on Friday said its board approved the addition of $750,000 to its share-repurchase plans.The addition comes on top of the roughly $257 million already authorized under the company's buyback plans.Aetna said it plans to continue buying shares on the open market.The...

Advertisement

Assessing positive outcomes of phase III trials

December 3, 2010 11:35 am | by EurekAlert | Comments

(Journal of the National Cancer Institute) Randomized phase III studies should be designed to find out whether a new drug or treatment makes a meaningful difference in patients' survival or quality of life, according to a commentary published online Dec. 3 in the Journal of the...

TOPICS:

Unique Needs and Outcomes of Pregnant Women with Breast Cancer Identified

December 3, 2010 9:32 am | by AACR | Comments

SAN ANTONIO - Do not delay treatment of breast cancer just because a woman is pregnant, said lead researcher Sibylle Loibl, Dr. med, of the German Breast Group.

TOPICS:

UBC/CFRI project receives $7 million to reduce maternal, fetal and newborn deaths

December 3, 2010 7:41 am | by EurekAlert | Comments

(University of British Columbia) The University of British Columbia has received a $7 million grant from the Bill & Melinda Gates Foundation. UBC researchers working at the Child & Family Research Institute will test new strategies for the monitoring, prevention, and treatment of...

TOPICS:

Workshop on MicroPackaging & Thermal Management - Advanced program and registration

December 3, 2010 7:40 am | by I-Micronews | Comments

IMAPS France released the advanced program of the event to be held on La Rochelle on February 2 & 3, 2011.

Summary Information for: SEDASYS? Computer-Assisted Personalized Sedation System(3)

December 3, 2010 7:39 am | by U.S. Food & Drug Administration | Comments

Information for SEDASYS? Computer-Assisted Personalized Sedation System (P080009).

Sermo Study shows 70% of Specialists are Ready to Replace Warfarin

December 3, 2010 7:38 am | by Bio-Medicine.Org | Comments

CAMBRIDGE, Mass., Dec. 3, 2010 /- Sermo ( http://www.sermo.com ), the world's largest online community for physicians, today announced a free Sermo Report titled, " Potential Replacements for Coumadin (warfarin) ." The report gathered feedback from physicians about awareness and...

TOPICS:

Streamline Health to Announce Third Quarter Fiscal Year 2010 Financial Results on Wednesday, December 8

December 3, 2010 7:38 am | by Bio-Medicine.Org | Comments

CINCINNATI, Dec. 3, 2010 /- Streamline Health Solutions, Inc. (Nasdaq: STRM ) announced today that it will release third quarter fiscal year 2010 financial results for the period ended October 31, 2010 on Wednesday, December 8, 2010 after the market closes. The Company will conduct a...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading